Tocqueville Asset Management’s BioSpecifics Technologies Corp. BSTC Stock Holding History

Tocqueville Asset Management’s Portfolio BSTC Stock Details BSTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-16,000	Closed	-$731K	–	867
2016 Q3	$731K	Sell	16,000 -4,000	-20%	-$161K	0.01%	556
2016 Q2	$799K	Hold	20,000	–	–	0.01%	539
2016 Q1	$696K	Hold	20,000	–	–	0.01%	559
2015 Q4	$859K	Hold	20,000	–	–	0.01%	568
2015 Q3	$871K	Hold	20,000	–	–	0.01%	588
2015 Q2	$1.03M	Sell	20,000 -5,000	-20%	-$213K	0.01%	568
2015 Q1	$979K	Buy	25,000 +5,000	+25%	+$196K	0.01%	590
2014 Q4	$772K	Sell	20,000 -5,000	-20%	-$191K	0.01%	625
2014 Q3	$883K	Buy	25,000 +7,500	+43%	+$220K	0.01%	525
2014 Q2	$472K	Buy	17,500 +7,500	+75%	+$195K	﹤0.01%	741
2014 Q1	$259K	Buy	+10,000	New	+$240K	﹤0.01%	736

Other funds holding BSTC

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

ECP

Elk Creek Partners Denver, Colorado $582M AUM 10.23% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Tocqueville Asset Management's BSTC Position: Q4 2016 in Review

Tocqueville Asset Management sold out of BioSpecifics Technologies Corp. (BSTC) in Q4 2016, closing a stake of 16,000 shares — an estimated $731K sold.

Tocqueville Asset Management first reported a position in BSTC in Q1 2014 and held it in 11 quarters. The position peaked at $1.03M in Q2 2015. 96 funds tracked by Wall St. Rank hold BSTC as of Q4 2016.

Tocqueville Asset Management reported no remaining BioSpecifics Technologies Corp. position as of Q4 2016 after selling out during the quarter.
Tocqueville Asset Management sold 16,000 BioSpecifics Technologies Corp. shares in Q4 2016, an estimated $731K.
Tocqueville Asset Management first reported a position in BioSpecifics Technologies Corp. in Q1 2014 and held it in 11 quarters.
Tocqueville Asset Management's BioSpecifics Technologies Corp. position peaked at $1.03M in Q2 2015.
96 funds tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q4 2016.

Based on Tocqueville Asset Management's 13F filing for Q4 2016, filed 30 Jan 2017.